We are live on ! Find out more
ENFN

Enfusion, Inc.

Delisted

ENFN was delisted on the 17th of April, 2025.

95 hedge funds and large institutions have $811M invested in Enfusion, Inc. in 2024 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 40 increasing their positions, 18 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,956% more call options, than puts

Call options by funds: $365K | Put options by funds: $9K

317% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 6

122% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 18

25% more funds holding

Funds holding: 7695 (+19)

25% more funds holding in top 10

Funds holding in top 10: 45 (+1)

2% less capital invested

Capital invested by funds: $830M → $811M (-$19M)

Holders
95
Holders Change
+19
Holders Change %
+25%
% of All Funds
1.37%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
25
Increased
40
Reduced
18
Closed
6
Calls
$365K
Puts
$9K
Net Calls
+$356K
Net Calls Change
+$111K
Name Holding Trade Value Shares
Change
Change in
Stake
State Board of Administration of Florida Retirement System
101
State Board of Administration of Florida Retirement System
Florida
-$104K -10,770 Closed

ENFN Hedge Fund Activity: Q1 2024 in Review

95 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Enfusion, Inc. (ENFN) for Q1 2024, worth a combined $811M — down 2.3% from $830M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ENFN positions and 6 closed out — a net gain of 19 holders — while 40 added to existing stakes and 18 trimmed.

The largest buyer was Lead Edge Capital Management, opening a new position worth an estimated $7.49M. The largest seller was Brown Capital Management, cutting an estimated $16.2M.

  • 95 institutional investors held Enfusion, Inc. (ENFN) as of Q1 2024, up from 76 in Q4 2023.
  • Funds reported $811M of Enfusion, Inc. stock for Q1 2024, down 2.3% quarter-over-quarter.
  • 25 funds opened new Enfusion, Inc. positions in Q1 2024 and 6 closed out, a net change of +19 holders.
  • The largest Enfusion, Inc. buyer in Q1 2024 was Lead Edge Capital Management, an estimated $7.49M added.
  • The largest Enfusion, Inc. seller in Q1 2024 was Brown Capital Management, an estimated $16.2M sold.

Based on aggregated 13F filings for Q1 2024.